年轻BRCA1/BRCA2突变携带者的乳腺癌预后:一项回顾性医院对象研究
F Hego1, M Barthoulot2, S Chretien1
1Department of Medical Oncology, Breast Cancer Unit, Lille Oscar Lambret Center, 3 rue Frédéric Combemale, 59020 Lille, France; Lille University, Faculty of Medicine Henri Warembourg, 2 Av. Eugène Avinée, 59120 Loos, France.
Clinical oncology (Royal College of Radiologists (Great Britain))
|November 6, 2024
概括
在患有乳腺癌的年轻女性中,生殖系BRCA1/2突变 (gBRCAm) 不会显著影响整体存活率或无病存活率. 这项研究发现没有明确的证据表明gBRCAm载体和非载体之间的结果有差异.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
- 临床研究 临床研究
背景情况:
- 在乳腺癌患者的生殖系BRCA1/2突变 (gBRCAm) 的预后影响方面存在相互矛盾的结果.
- 由于潜在的遗传影响,早期发病的乳腺癌 (<30年) 需要进行具体的调查.
研究的目的:
- 调查与非携带者相比,具有gBRCA突变和早期发病的乳腺癌患者的结局.
- 为了澄清gBRCA1/2突变在年轻患者队列中的预后意义.
主要方法:
- 对149名早期乳腺癌患者 (2005-2019) 的回顾性研究.
- 评估整体存活率 (OS) 和无病存活率 (DFS).
- 使用考克斯的比例危险模型计算的危险比率 (HR).
主要成果:
- 18.8%的患者是gBRCAm携带者.
- 在多变量分析后,运营商和非运营商之间的OS没有显著差异 (HR=1.90,p=0.22).
- 运营商和非运营商之间的DFS没有显著差异 (HR=1.39,p=0.42).
结论:
- 没有明确的证据表明gBRCA1/2突变在非常早期发病的乳腺癌患者中显著影响OS.
- 研究结果表明,gBRCAm状态可能不是这一特定人群生存的主要预后因素.
- 可能需要进一步的研究,以探索其他影响gBRCA突变的年轻乳腺癌患者结果的因素.
更多相关视频
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K